Dr. Reddy's Laboratories

Update in progress

RDY (NYSE)

Company RatingGood
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Dr. Reddy’s Laboratories Limited is a global integrated pharmaceutical company with operations in North America, Europe, India, Russia, and other regions. It has three segments: Global Generics; Pharmaceutical Services and Active Ingredients (PSAI); and Others. Global Generics develops and markets prescription and OTC products, including branded, generic, and biologics. PSAI produces APIs, intermediates, offers contract research, and makes steroids. Others focuses on oncology, inflammation, and differentiated formulations. Founded 1984, HQ in Hyderabad, India.

Company score

Sentiment: 2.59; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 4.63; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.85; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 1.60; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 2.10; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketNYSE (NYQ)
LocationIndia
CEOMr. Erez Israeli M.B.A.
Founded1984
Employees27,527
Websitewww.drreddys.com

Identifiers

ISINUS2561352038
FIGIBBG000NJ96L6
LEI335800OVDPY3DVZR2798
CUSIP256135203
CIK0001135951